Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19351989 | SYRINGE SHOCK ABSORBER FOR USE IN AN INJECTION DEVICE | October 2025 | January 2026 | Allow | 3 | 0 | 0 | Yes | No |
| 19223340 | INTRANASAL AND OLFACTORY DELIVERY DEVICES AND METHODS OF USE | May 2025 | December 2025 | Allow | 7 | 2 | 0 | Yes | No |
| 19192037 | ORAL DRUG DELIVERY DEVICE WITH COVER RELEASE | April 2025 | October 2025 | Allow | 5 | 1 | 0 | Yes | No |
| 19038367 | INTRANASAL AND OLFACTORY DELIVERY DEVICES AND METHODS OF USE | January 2025 | May 2025 | Allow | 3 | 1 | 0 | No | No |
| 19029194 | DRUG DELIVERY DEVICE WITH FEEDBACK MECHANISM | January 2025 | July 2025 | Allow | 6 | 1 | 0 | Yes | No |
| 19028589 | DRUG DELIVERY DEVICE WITH FEEDBACK MECHANISM | January 2025 | June 2025 | Allow | 5 | 1 | 0 | Yes | No |
| 19028358 | DRUG DELIVERY DEVICE WITH FEEDBACK MECHANISM | January 2025 | May 2025 | Allow | 4 | 1 | 0 | Yes | No |
| 19028997 | DRUG DELIVERY DEVICE WITH FEEDBACK MECHANISM | January 2025 | July 2025 | Allow | 6 | 1 | 0 | Yes | No |
| 19028896 | DRUG DELIVERY DEVICE WITH FEEDBACK MECHANISM | January 2025 | June 2025 | Allow | 5 | 1 | 0 | Yes | No |
| 19002415 | APPLICATOR AND MICRONEEDLE ARRAY PATCH DELIVERY SYSTEM | December 2024 | January 2026 | Allow | 12 | 2 | 1 | Yes | No |
| 19002468 | APPLICATOR FOR A MICRONEEDLE ARRAY PATCH DELIVERY SYSTEM | December 2024 | June 2025 | Allow | 5 | 1 | 0 | Yes | No |
| 18764716 | MULTI-FUNCTION ANALYTE MONITOR DEVICE AND METHODS OF USE | July 2024 | April 2025 | Allow | 10 | 2 | 0 | Yes | No |
| 18532090 | METHODS OF PREPARING BALLOON EXPANDABLE CATHETERS FOR CARDIAC AND VASCULAR INTERVENTIONS | December 2023 | February 2026 | Allow | 27 | 1 | 0 | No | No |
| 18387405 | TRANS MIDDLE EAR-INNER EAR FLUID FLOW IMPLEMENTATIONS | November 2023 | March 2026 | Abandon | 28 | 4 | 1 | No | No |
| 18370312 | SEPTUM HOUSING | September 2023 | February 2026 | Allow | 29 | 1 | 1 | Yes | No |
| 18469448 | MULTI-FUNCTION ANALYTE MONITOR DEVICE AND METHODS OF USE | September 2023 | January 2026 | Allow | 28 | 1 | 0 | No | No |
| 18368722 | BALLOON CATHETER WITH FORTIFIED PROXIMAL INFUSION OUTLET PORT, AND MANUFACTURING THEREOF | September 2023 | September 2025 | Allow | 24 | 1 | 0 | No | No |
| 18239646 | PRESSURE ACTUATED FLOW CONTROL DEVICE FOR GRAVITY IV SETS | August 2023 | March 2025 | Allow | 19 | 1 | 0 | Yes | No |
| 18224395 | METHOD AND DEVICE FOR ENHANCED COMPOSITION DELIVERY | July 2023 | April 2024 | Allow | 9 | 1 | 0 | No | No |
| 18352824 | ENTERAL FEEDING PUMP SYSTEMS, VALVE ASSEMBLIES THEREFOR AND FLUID FLOW CONTROL METHODS FOR SAME | July 2023 | July 2025 | Abandon | 24 | 2 | 0 | Yes | No |
| 18339142 | INFUSION LIQUID HEATING AND FLOW-VELOCITY-MONITORING SYSTEM FOR CLINICAL USE | June 2023 | February 2026 | Allow | 32 | 0 | 0 | Yes | No |
| 18325985 | ENTERAL FEEDING PUMP SYSTEMS, VALVE ASSEMBLIES THEREFOR AND FLUID FLOW CONTROL METHODS FOR SAME | May 2023 | January 2024 | Allow | 8 | 1 | 0 | Yes | No |
| 18199747 | SYRINGE PUMP | May 2023 | June 2025 | Allow | 25 | 1 | 0 | No | No |
| 18305560 | SUCTION DEVICE FOR SUCKING OBSTRUCTION IN RESPIRATORY TRACT AND USE METHOD THEREFOR | April 2023 | March 2026 | Allow | 35 | 2 | 0 | No | No |
| 18192581 | DRUG DELIVERY DEVICE AND METHOD OF OPERATION | March 2023 | November 2025 | Abandon | 32 | 4 | 0 | Yes | No |
| 18125254 | Angiogram Injections Using Electrocardiographic Synchronization | March 2023 | October 2025 | Allow | 30 | 1 | 0 | Yes | No |
| 18111765 | Process for Delivery of Viscous Drug Therapies | February 2023 | July 2025 | Allow | 29 | 1 | 1 | Yes | No |
| 18108449 | INTEGRATED VASCULAR DELIVERY SYSTEM | February 2023 | July 2025 | Allow | 29 | 1 | 0 | Yes | No |
| 18106850 | AUTOMATIC BREAST PUMP DEVICE | February 2023 | March 2026 | Allow | 37 | 1 | 0 | Yes | No |
| 18104344 | Trigger Arrangement for an Infusion Device | February 2023 | November 2025 | Allow | 33 | 2 | 0 | No | No |
| 18087944 | Safety Device for Shielding an Injection Needle of a Medical Container, and an Injection Device Including This Safety Device | December 2022 | January 2026 | Allow | 37 | 1 | 0 | No | No |
| 18083897 | Drug Delivery Device with a Cap | December 2022 | September 2025 | Allow | 33 | 1 | 0 | No | No |
| 17989367 | PRECISION STEERABLE AND ANGLED MEDICATION DELIVERY SYSTEM | November 2022 | October 2025 | Allow | 35 | 1 | 0 | Yes | No |
| 17956420 | INJECTOR DEVICE | September 2022 | September 2024 | Allow | 24 | 0 | 0 | No | No |
| 17935306 | DEVICE FOR MONITORING AND TREATING BRADYARRHYTHMIA | September 2022 | February 2023 | Allow | 5 | 1 | 0 | Yes | No |
| 17902329 | Selectively Controlling Fluid Flow Through a Fluid Pathway | September 2022 | July 2025 | Allow | 34 | 2 | 0 | Yes | No |
| 17901049 | Instrument Delivery Device with Nested Housing | September 2022 | December 2025 | Allow | 39 | 1 | 0 | Yes | No |
| 17896452 | AUTO-INJECTOR WITH ACTIVE AGENT CONTAINER LATCHING | August 2022 | December 2024 | Allow | 28 | 1 | 0 | Yes | No |
| 17893066 | WIRELESS PATCH SYSTEM FOR TRANSDERMAL, TRANSMUCOSAL AND DENTAL ELECTRICAL DRUG DELIVERY | August 2022 | October 2025 | Allow | 38 | 1 | 0 | No | No |
| 17820385 | ENTERAL FEEDING PUMP SYSTEMS, VALVE ASSEMBLIES THEREFOR AND FLUID FLOW CONTROL METHODS FOR SAME | August 2022 | June 2023 | Allow | 10 | 1 | 0 | Yes | No |
| 17889318 | EAR CANAL MEDICATION APPLICATOR | August 2022 | February 2026 | Abandon | 42 | 0 | 1 | No | No |
| 17886137 | PREFILLED SYRINGE INJECTOR | August 2022 | November 2025 | Allow | 39 | 1 | 0 | Yes | No |
| 17883302 | SYSTEMS AND METHODS FOR CROSS-LINKING TREATMENTS OF AN EYE | August 2022 | June 2025 | Allow | 34 | 1 | 0 | Yes | No |
| 17797657 | IMPROVED INJECTION DEVICE | August 2022 | October 2025 | Allow | 38 | 1 | 0 | No | No |
| 17759434 | SYSTEMS AND METHODS FOR A CATHETER STABILIZATION AND OCCLUDER APPARATUS | July 2022 | January 2026 | Allow | 41 | 1 | 1 | Yes | No |
| 17868600 | SUBCUTANEOUS ACCESS HUB WITH MULTIPLE CANNULA PORTS | July 2022 | May 2025 | Allow | 34 | 1 | 0 | Yes | No |
| 17867224 | Priming System for Infusion Devices | July 2022 | April 2025 | Allow | 33 | 1 | 0 | Yes | No |
| 17758903 | A MEDICAL DEVICE | July 2022 | April 2025 | Allow | 33 | 1 | 0 | Yes | No |
| 17792510 | ACTIVATION DEVICE AND ODOR REMOVAL DEVICE INCLUDING SAME | July 2022 | March 2026 | Allow | 44 | 1 | 0 | No | No |
| 17791725 | MICRONEEDLE APPLICATOR | July 2022 | January 2026 | Abandon | 42 | 0 | 1 | No | No |
| 17855857 | Delivery System And Method For Delivering Material To A Target Site During A Medical Procedure | July 2022 | June 2025 | Allow | 36 | 2 | 0 | Yes | No |
| 17844415 | DOSE SETTING MECHANISM AND METHOD OF LOCKING AN INJECTION PEN | June 2022 | February 2026 | Abandon | 44 | 1 | 0 | No | No |
| 17807736 | EXTERNAL CATHETER STABILIZER | June 2022 | April 2025 | Allow | 34 | 1 | 1 | No | No |
| 17843358 | WIRE DELIVERY DEVICE, AND DRUG SOLUTION INJECTION DEVICE | June 2022 | January 2026 | Abandon | 43 | 1 | 0 | No | No |
| 17664546 | DEVICE, SYSTEM, AND METHOD FOR APPLYING A PHARMACEUTICAL FLUID | May 2022 | January 2026 | Allow | 44 | 1 | 0 | Yes | No |
| 17749265 | Systems and Methods for Precision or Personal Pharmaceutical Dosing | May 2022 | April 2025 | Allow | 34 | 1 | 0 | Yes | No |
| 17740153 | MONITORING UPSTREAM FLOW CHARACTERISTICS FOR A PUMP | May 2022 | March 2025 | Allow | 35 | 1 | 0 | Yes | No |
| 17774932 | ASSEMBLY, CASSETTE AND MEDICAMENT DELIVERY DEVICE | May 2022 | July 2025 | Allow | 39 | 1 | 0 | Yes | No |
| 17737270 | FLUID DELIVERY APPARATUS HAVING A CONTROLLER ASSEMBLY AND METHOD OF USE | May 2022 | March 2026 | Allow | 46 | 1 | 0 | No | No |
| 17661387 | Guidewire Retraction Device | April 2022 | April 2023 | Allow | 12 | 2 | 0 | Yes | No |
| 17720175 | SYSTEMS AND METHODS TO AUTOMATICALLY ADMINISTER A PSYCHOACTIVE SUBSTANCE TO AN AIRWAY OF A USER BASED ON A DETECTED EVENT OR CONDITION | April 2022 | January 2023 | Allow | 9 | 2 | 0 | Yes | No |
| 17719418 | SYRINGE WITH FLEXIBLE RESERVOIR AND METHOD OF USE | April 2022 | August 2023 | Abandon | 16 | 2 | 0 | No | No |
| 17767330 | INTRAURETHRAL MEDICATION DOSAGE FORM AND DEVICE | April 2022 | February 2026 | Allow | 47 | 2 | 0 | Yes | No |
| 17715891 | PRESSURE-REGULATING CONNECTOR FOR INFUSION | April 2022 | February 2025 | Allow | 35 | 1 | 0 | Yes | No |
| 17715047 | CONNECTOR ADAPTED TO ATTACH AN IRRIGATION CATHETER TO TUBING OF AN ANAL OR STOMAL IRRIGATION SYSTEM | April 2022 | April 2025 | Allow | 37 | 1 | 0 | Yes | No |
| 17754556 | ATRAUMATIC REMOVABLE CELL ENCAPSULATION DEVICES | April 2022 | July 2025 | Allow | 39 | 1 | 1 | No | No |
| 17707863 | RADIOACTIVE CONDUIT AND METHOD FOR IN VIVO TREATMENT OF TUMORS | March 2022 | December 2023 | Allow | 21 | 2 | 1 | Yes | No |
| 17706708 | IV FLOW REGULATOR | March 2022 | March 2025 | Allow | 35 | 1 | 0 | Yes | No |
| 17656531 | DRUG DELIVERY DEVICES WITH DRUG-PERMEABLE COMPONENT AND METHODS | March 2022 | May 2025 | Allow | 38 | 1 | 1 | Yes | No |
| 17655900 | DEVICE AND METHOD FOR MONITORING AND TREATING ADVANCED BRADYCARDIA | March 2022 | June 2022 | Allow | 3 | 1 | 0 | Yes | No |
| 17701439 | LAMPREY LOCK DEVICE | March 2022 | September 2022 | Allow | 6 | 1 | 0 | Yes | No |
| 17685389 | NASAL ASPIRATOR CAPABLE OF EFFECTIVELY PREVENTING BACKFLOW AND CONTROL METHOD THEREOF | March 2022 | August 2022 | Allow | 5 | 1 | 0 | No | No |
| 17639641 | PATIENT LINE AIR DETECTION AND REUSE PREVENTION | March 2022 | January 2025 | Allow | 35 | 1 | 0 | Yes | No |
| 17673227 | MICRONEEDLE ASSEMBLY | February 2022 | October 2025 | Allow | 44 | 1 | 0 | Yes | No |
| 17669918 | Adjustable Medium Diverter | February 2022 | May 2025 | Abandon | 40 | 1 | 0 | No | No |
| 17590175 | INJECTOR AND METHOD OF ASSEMBLY | February 2022 | February 2025 | Allow | 37 | 1 | 0 | Yes | No |
| 17588228 | MINIMALLY TRAUMATIC TROCAR METHOD FOR SUBCUTANEOUS MEDICATION DELIVERY | January 2022 | December 2025 | Allow | 46 | 1 | 0 | Yes | No |
| 17645503 | MICRONEEDLE ARRAYS AND METHODS OF MAKING AND USING | December 2021 | February 2026 | Abandon | 50 | 2 | 0 | No | No |
| 17558577 | METHODS FOR DELIVERY OF THERAPEUTIC MATERIALS TO TREAT CANCER | December 2021 | October 2022 | Allow | 10 | 2 | 0 | Yes | No |
| 17549974 | Systems and Methods for Guidewire Retraction | December 2021 | May 2022 | Allow | 5 | 1 | 0 | Yes | No |
| 17617052 | ELECTRONICALLY-CONTROLLED CAPTURING SYSTEM FOR DRUG DELIVERY SYSTEMS | December 2021 | July 2025 | Allow | 44 | 1 | 0 | No | No |
| 17518044 | ELECTROCHEMICAL PUMP UNIT OF MESH COMBINED ELECTRODE | November 2021 | February 2025 | Allow | 40 | 1 | 0 | Yes | No |
| 17512040 | SYRINGE SHOCK ABSORBER FOR USE IN AN INJECTION DEVICE | October 2021 | January 2026 | Allow | 51 | 4 | 0 | Yes | No |
| 17498525 | EVENT CAPTURE DEVICE FOR MEDICATION DELIVERY INSTRUMENTS | October 2021 | January 2025 | Allow | 39 | 1 | 0 | Yes | No |
| 17493118 | VOLUME MONITORING SYSTEMS | October 2021 | March 2025 | Abandon | 41 | 1 | 0 | No | No |
| 17489620 | SUBARACHNOID FLUID MANAGEMENT METHOD AND SYSTEM WITH VARYING RATES | September 2021 | February 2025 | Allow | 41 | 1 | 1 | Yes | No |
| 17489625 | SUBARACHNOID FLUID MANAGEMENT METHOD AND SYSTEM | September 2021 | February 2025 | Allow | 41 | 1 | 1 | Yes | No |
| 17448618 | SURGICAL HUMIDIFIER CONTROL | September 2021 | January 2025 | Allow | 40 | 1 | 0 | Yes | No |
| 17482715 | MEDICAL DEVICE INCLUDING SHAFT WITH FLAT WIRE COIL | September 2021 | September 2025 | Allow | 47 | 2 | 0 | Yes | No |
| 17476426 | MEDICAL DEVICE AND METHOD FOR LIMITING THE USE OF THE MEDICAL DEVICE | September 2021 | June 2022 | Allow | 9 | 2 | 0 | Yes | No |
| 17462130 | DRUG DELIVERY VIA MECHANICAL VIBRATION BALLOON | August 2021 | September 2024 | Allow | 37 | 1 | 0 | Yes | No |
| 17406760 | MEDIUM INJECTION DIVERSION AND MEASUREMENT | August 2021 | January 2025 | Abandon | 41 | 1 | 0 | No | No |
| 17405656 | INTRAVENOUS CATHETER DEVICE WITH INTEGRATED EXTENSION TUBE | August 2021 | September 2024 | Allow | 37 | 1 | 0 | Yes | No |
| 17398370 | SYSTEMS AND METHODS FOR CONTROLLED DELIVERY OF ANALGESIC AND HYPNOTIC AGENTS | August 2021 | April 2025 | Allow | 44 | 1 | 0 | Yes | No |
| 17393187 | SUCTION DEVICE FOR SUCKING OBSTRUCTION IN RESPIRATORY TRACT AND USE METHOD THEREFOR | August 2021 | March 2023 | Allow | 19 | 3 | 0 | Yes | No |
| 17425539 | DETACHABLE-TIP BALLOON MICROCATHETER FOR EMBOLIZATION OF VASCULAR PATHOLOGY | July 2021 | October 2025 | Allow | 51 | 1 | 1 | No | No |
| 17355061 | Medicament Delivery Device with Rotator Retaining the Plunger Rod | June 2021 | September 2024 | Allow | 38 | 1 | 0 | No | No |
| 17350883 | INJECTOR AND METHOD OF ASSEMBLY | June 2021 | November 2021 | Allow | 5 | 0 | 0 | Yes | No |
| 17335996 | Intravenous Fluid Delivery System and Apparatus | June 2021 | August 2023 | Allow | 27 | 5 | 1 | Yes | No |
| 17244898 | RETRACTABLE NEEDLE CATHETER DELIVERY APPARATUS | April 2021 | October 2021 | Allow | 6 | 1 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner SHAH, NILAY J.
With a 25.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 20.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner SHAH, NILAY J works in Art Unit 3783 and has examined 355 patent applications in our dataset. With an allowance rate of 78.3%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 37 months.
Examiner SHAH, NILAY J's allowance rate of 78.3% places them in the 46% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by SHAH, NILAY J receive 2.28 office actions before reaching final disposition. This places the examiner in the 64% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by SHAH, NILAY J is 37 months. This places the examiner in the 34% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +46.8% benefit to allowance rate for applications examined by SHAH, NILAY J. This interview benefit is in the 91% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 28.3% of applications are subsequently allowed. This success rate is in the 51% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.
This examiner enters after-final amendments leading to allowance in 38.2% of cases where such amendments are filed. This entry rate is in the 58% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants request a pre-appeal conference (PAC) with this examiner, 83.3% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 65% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.
This examiner withdraws rejections or reopens prosecution in 65.2% of appeals filed. This is in the 46% percentile among all examiners. Of these withdrawals, 66.7% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.
When applicants file petitions regarding this examiner's actions, 42.1% are granted (fully or in part). This grant rate is in the 34% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 47% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 2.2% of allowed cases (in the 69% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.